We are live on ! Find out more
CJL

Cyrus J. Lawrence Portfolio holdings

AUM $26.4M
1-Year Est. Return 16.63%
This Fund
S&P 500
This Quarter Est. Return
+10.03%
1 Year Est. Return
+16.63%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$335M
AUM Growth
-$174M
Cap. Flow
-$9.08M
Cap. Flow %
-2.71%
Top 10 Hldgs %
34.41%
Holding
226
New
40
Increased
18
Reduced
59
Closed
18

Top Buys

Rank Stock Value
1
NEM icon
Newmont
NEM
+$5.8M
2
AES icon
AES
AES
+$5.74M
3
PEP icon
PepsiCo
PEP
+$5.02M
4
DE icon
Deere & Co
DE
+$2.43M
5
ROK icon
Rockwell Automation
ROK
+$1.98M

Top Sells

Rank Stock Value
1
ACN icon
Accenture
ACN
+$5.49M
2
WOOF icon
Petco
WOOF
+$3.52M
3
META icon
Meta Platforms (Facebook)
META
+$3.29M
4
TMO icon
Thermo Fisher Scientific
TMO
+$3.24M
5
QCOM icon
Qualcomm
QCOM
+$3.23M

Sector Composition

Rank Sector Weight
1 Technology 21.43%
2 Healthcare 18%
3 Financials 12.61%
4 Consumer Discretionary 8.72%
5 Industrials 8.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$3.67T
$20.1M 5.99%
83,640
-1,012
-1% -$243K
AAPL icon
2
Apple
AAPL
$4.61T
$14.5M 4.33%
111,622
-4,494
-4% -$642K
NEE icon
3
NextEra Energy
NEE
$175B
$11.2M 3.35%
134,363
-715
-0.5% -$57.8K
CVS icon
4
CVS Health
CVS
$123B
$11M 3.29%
118,402
-2,314
-2% -$223K
SLB icon
5
SLB Ltd
SLB
$84.7B
$10.9M 3.25%
203,783
-423
-0.2% -$21.1K
GOOGL icon
6
Alphabet (Google) Class A
GOOGL
$4.14T
$10.8M 3.21%
121,908
-6,706
-5% -$637K
XOM icon
7
ExxonMobil
XOM
$661B
$9.73M 2.9%
88,209
-390
-0.4% -$41.8K
JNJ icon
8
Johnson & Johnson
JNJ
$649B
$9.47M 2.83%
53,614
-251
-0.5% -$43.3K
COST icon
9
Costco
COST
$404B
$8.82M 2.63%
19,317
-237
-1% -$116K
PFE icon
10
Pfizer
PFE
$158B
$8.8M 2.63%
171,760
-1,588
-0.9% -$76.1K
HD icon
11
Home Depot
HD
$313B
$8.78M 2.62%
27,789
-629
-2% -$192K
UNH icon
12
UnitedHealth
UNH
$360B
$8.66M 2.58%
16,337
-119
-0.7% -$63K
PANW icon
13
Palo Alto Networks
PANW
$275B
$8.63M 2.58%
123,748
-3,478
-3% -$279K
J icon
14
Jacobs Solutions
J
$16.9B
$8.4M 2.51%
84,571
-664
-0.8% -$65.2K
CB icon
15
Chubb
CB
$130B
$8.02M 2.39%
36,348
-233
-0.6% -$48.5K
LLY icon
16
Eli Lilly
LLY
$1T
$8M 2.39%
21,858
-79
-0.4% -$28K
MA icon
17
Mastercard
MA
$500B
$7.91M 2.36%
22,744
-196
-0.9% -$64.5K
JPM icon
18
JPMorgan Chase
JPM
$940B
$7.66M 2.29%
57,134
-354
-0.6% -$44.9K
ADBE icon
19
Adobe
ADBE
$102B
$7.65M 2.28%
22,736
-449
-2% -$144K
ULTA icon
20
Ulta Beauty
ULTA
$23.5B
$7.49M 2.24%
15,972
-203
-1% -$87.5K
TMO icon
21
Thermo Fisher Scientific
TMO
$223B
$7.49M 2.24%
13,600
-6,112
-31% -$3.24M
APD icon
22
Air Products & Chemicals
APD
$66.3B
$7.22M 2.16%
23,429
-82
-0.3% -$23.1K
SPGI icon
23
S&P Global
SPGI
$127B
$7.2M 2.15%
21,505
-377
-2% -$124K
DE icon
24
Deere & Co
DE
$184B
$6.79M 2.03%
15,843
+5,989
+61% +$2.43M
ROK icon
25
Rockwell Automation
ROK
$47.7B
$6.71M 2%
26,056
+7,885
+43% +$1.98M

Similar funds

Cyrus J. Lawrence's Q4 2022 Portfolio in Review

As of Q4 2022, Cyrus J. Lawrence held 226 positions worth $335M, down 34% from $509M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Cyrus J. Lawrence's Q4 2022 filing shows 40 new, 18 increased, 59 reduced and 18 closed positions. Its largest new stake was Newmont: 129,919 shares worth $6.13M. The largest sale was Accenture, an estimated $5.49M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.

  • Cyrus J. Lawrence's largest Q4 2022 buy was Newmont: 129,919 shares worth $6.13M.
  • Cyrus J. Lawrence added most to PepsiCo in Q4 2022, an estimated $5.02M increase.
  • Cyrus J. Lawrence's biggest Q4 2022 reduction was Accenture, cutting an estimated $5.49M.
  • Cyrus J. Lawrence fully exited iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2022, selling an estimated $342K.
  • Cyrus J. Lawrence's ten largest holdings make up 34% of its $335M portfolio in Q4 2022.
  • Cyrus J. Lawrence opened 40 new positions and closed 18 in Q4 2022.
  • Cyrus J. Lawrence's portfolio value fell 34% quarter-over-quarter to $335M.

Based on Cyrus J. Lawrence's 13F filing for Q4 2022, filed 10 Feb 2023.